CTSA K12 Program at Indiana University
印第安纳大学 CTSA K12 项目
基本信息
- 批准号:10622098
- 负责人:
- 金额:$ 97.1万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-07-01 至 2028-06-30
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAddressAreaAwardCaliberClinical ResearchClinical SciencesCompanionsDevelopmentEnsureFundingGoalsGrantIndianaIndividualInstitutionKnowledgeLeadershipMentored Clinical Scientist Development ProgramMentorsPopulationPositioning AttributePrincipal InvestigatorProgram DevelopmentRecording of previous eventsResearchResearch ActivityResourcesScienceScientistSecureTimeTrainingTranslational ResearchUniversitiesWorkWorkforce Developmentcareercareer developmentdesignearly-career facultyequity, diversity, and inclusionevidence baseexperiencefaculty mentorprogramsrecruitskills
项目摘要
Project Summary/Abstract
The Indiana Clinical and Translational Sciences Institute (CTSI) has a sustained record of accomplishment in
preparing early career Scholars through its workforce development program. Since 2008, our program has
prepared 72 KL2 Scholars from our state's three major research universities with most retained in academic
positions (90%) and obtaining external funding as principal investigators (81%) including 36 R01s, 36 other R-
level awards, and 26 K or equivalent career awards. The state-wide reach of our program ensures a broad,
diverse pool of Scholars, faculty mentors, and breadth of translational research.
The primary objective of this new K12 Mentored Research Career Development Program at the Indiana
CTSI is to provide a diverse group of early career faculty Scholars intensive mentored career development
experiences that lead to research independence and prepare them for leadership positions in clinical and
translational science. To maximize K12 programmatic impact we have designed our proposed program to
address six core areas of clinical and translational science including core knowledge, team-based science,
leadership/management, mentoring training, diversity, and career visibility/enhancement. Protected time for
intensive mentored research activity is carefully balanced with required curricular content and a broad range of
elective experiences that capitalize on available Indiana CTSI resources and ultimately are selected based on
individual Scholar needs. Taken together these components assure training in a fundamental skillset for early
career clinical and translational research scientists. Given the historically low rates of underrepresented
individuals moving into scientific careers, we propose intentional evidence-based efforts to continue to recruit,
support, and fund these individuals. Our goal is to not only sustain our current diversity metrics, which exceed
those of our academic institutions, but to resemble the diversity of our state's population more closely. We
propose the following aims to achieve K12 program goals:
1) Support and accelerate Scholar transition to independent careers in clinical and translational research.
2) Catalyze Diversity, Equity, and Inclusion (DEI) efforts throughout the KL2 program to advance the
diversity of Scholars, their teams, and their translational work.
3) Leverage institutional strengths and companion CTSA hub partnerships to optimize Scholar
development including career visibility and enhancement.
We anticipate funding 25 Scholars over 5 years with each Scholar spending two years on the K12, with the
goal to obtain a federally funded K or R level grant. We have a successful history of securing institutional funds
to support additional Scholars (increasing the positions offered by as much as 50%). We are confident that our
proposed program will attract diverse, high caliber applicants and mentor them toward developing impactful
careers in clinical and translational science.
项目摘要/摘要
印第安纳州的临床和转化科学研究所(CTSI)在
通过其劳动力发展计划来准备早期的职业学者。自2008年以来,我们的计划有
从我们州的三个主要研究中准备了72个KL2学者,其中最多保留在学术中
职位(90%)并获得主要研究人员的外部资金(81%),包括36个R01,其他36个R-
级别的奖项和26 K或同等职业奖。我们计划的全州范围可确保广泛的
各种各样的学者,教师导师和转化研究的广度。
这个新的K12的主要目标指导了印第安纳州的研究职业发展计划
CTSI将提供各种各样的早期职业学者学者密集的指导职业发展
导致研究独立性并为他们准备领导职务的经验
翻译科学。为了最大化K12编程影响,我们已经设计了我们建议的程序
探讨临床和转化科学的六个核心领域,包括核心知识,基于团队的科学,
领导力/管理,指导培训,多样性和职业知名度/增强性。受保护的时间
密集的指导研究活动仔细平衡了所需的课程内容和广泛的范围
选择可用的印第安纳州CTSI资源的选修经验,并最终根据
个人学者的需求。结合这些组件在早期的基本技能中确保培训
职业临床和转化研究科学家。鉴于历史上代表性不足的比率很低
个人进入科学职业,我们提出有意的基于证据的努力,以继续招募,
支持,并为这些人提供资金。我们的目标不仅要维持我们当前的多样性指标
我们的学术机构的那些人,但更像是我们州人口的多样性。我们
提出以下目的实现K12计划目标:
1)支持和加速学者过渡到临床和转化研究中的独立职业。
2)在整个KL2计划中催化多样性,公平和包容性(DEI)努力
学者,他们的团队及其翻译工作的多样性。
3)利用机构优势和伴侣CTSA中心合作伙伴关系来优化学者
发展包括职业知名度和增强。
我们预计每位学者在K12上花费了两年的时间,将在5年内为25名学者提供资金,其中
获得联邦资助的K或R级赠款的目标。我们有一个成功获得机构资金的历史
为了支持其他学者(增加了多达50%的职位)。我们有信心我们的
拟议的计划将吸引多样化的高素质申请人,并指导他们发展有影响力的
临床和转化科学的职业。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SAMIR KUMAR GUPTA其他文献
SAMIR KUMAR GUPTA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SAMIR KUMAR GUPTA', 18)}}的其他基金
Treating insomnia to reduce inflammation in HIV
治疗失眠以减少艾滋病毒炎症
- 批准号:
10252447 - 财政年份:2021
- 资助金额:
$ 97.1万 - 项目类别:
Treating insomnia to reduce inflammation in HIV
治疗失眠以减少艾滋病毒炎症
- 批准号:
10414994 - 财政年份:2021
- 资助金额:
$ 97.1万 - 项目类别:
HIV, Intermediate Monocytes, and Endothelial Colony Forming Cells
HIV、中间单核细胞和内皮集落形成细胞
- 批准号:
9100524 - 财政年份:2015
- 资助金额:
$ 97.1万 - 项目类别:
A PILOT STUDY OF PENTOXIFYLLINE IN REDUCING SYSTEMIC INFLAMMATION AND IMPROVING
己酮可可碱减少和改善全身炎症的初步研究
- 批准号:
7717581 - 财政年份:2007
- 资助金额:
$ 97.1万 - 项目类别:
HIV-RELATED PROTEINURIA AND ENDOTHELIAL DYSFUNCTION
HIV 相关蛋白尿和内皮功能障碍
- 批准号:
7717509 - 财政年份:2007
- 资助金额:
$ 97.1万 - 项目类别:
A PILOT STUDY OF SALSALATE IN REDUCING SYSTEMIC INFLAMMATION AND IMPROVING EN
水杨酸减少全身炎症和改善 EN 的试点研究
- 批准号:
7717570 - 财政年份:2007
- 资助金额:
$ 97.1万 - 项目类别:
A PILOT STUDY TO DETERMINE THE IMPACT ON DYSLIPIDEMIA OF THE ADDITION OF TENOFOV
确定添加替诺福夫对血脂异常影响的试点研究
- 批准号:
7717546 - 财政年份:2007
- 资助金额:
$ 97.1万 - 项目类别:
A PILOT STUDY OF SALSALATE IN REDUCING SYSTEMIC INFLAMMATION AND IMPROVING EN
水杨酸减少全身炎症和改善 EN 的试点研究
- 批准号:
7606473 - 财政年份:2006
- 资助金额:
$ 97.1万 - 项目类别:
HIV-RELATED PROTEINURIA AND ENDOTHELIAL DYSFUNCTION
HIV 相关蛋白尿和内皮功能障碍
- 批准号:
7606412 - 财政年份:2006
- 资助金额:
$ 97.1万 - 项目类别:
A PILOT STUDY TO DETERMINE THE IMPACT ON DYSLIPIDEMIA OF THE ADDITION OF TENOFOV
确定添加替诺福夫对血脂异常影响的试点研究
- 批准号:
7606449 - 财政年份:2006
- 资助金额:
$ 97.1万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
相似海外基金
The Proactive and Reactive Neuromechanics of Instability in Aging and Dementia with Lewy Bodies
衰老和路易体痴呆中不稳定的主动和反应神经力学
- 批准号:
10749539 - 财政年份:2024
- 资助金额:
$ 97.1万 - 项目类别:
MAIT cells in lupus skin disease and photosensitivity
MAIT 细胞在狼疮皮肤病和光敏性中的作用
- 批准号:
10556664 - 财政年份:2023
- 资助金额:
$ 97.1万 - 项目类别:
The contribution of air pollution to racial and ethnic disparities in Alzheimer’s disease and related dementias: An application of causal inference methods
空气污染对阿尔茨海默病和相关痴呆症的种族和民族差异的影响:因果推理方法的应用
- 批准号:
10642607 - 财政年份:2023
- 资助金额:
$ 97.1万 - 项目类别:
Translational Research and Implementation Science for Nurses (TRAIN) Program 2.0
护士转化研究和实施科学 (TRAIN) 计划 2.0
- 批准号:
10680769 - 财政年份:2023
- 资助金额:
$ 97.1万 - 项目类别: